Buy or sell Relay Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Relay Therapeutics Stock

Analyze the movement of proteins inside human cells

About Relay Therapeutics Stock

Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.

Funding History

September 2016$57.0M
December 2017$63.0M
December 2018$400M


President & CEO

Sanjiv Patel

Chief Scientific Officer and Co-Founder

Mark Murcko

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Relay Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 190K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: